Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD)

Clinical trial NCT04995081 · COMPLETED

Trial details

NCT number: NCT04995081
Sponsor: Hope Biosciences Research Foundation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2021-07-16
Primary completion: 2025-10-03
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.